WaveMan
WaveMan · Company
VSEE · Vsee Health, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

VSEE Vsee Health (VSEE) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-health services · CIK 0001864531
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
15
13F, latest reported quarter

Vsee Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for VSEE HEALTH, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing

no insider purchases or sales on record

0 transactions on record
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
15 funds bought in last quarter
below 85% of Healthcare Services
Revenue
+40.3% year over year
more than 88% of Healthcare Services
Margin
-100.6% net margin
below 92% of Healthcare Services
Buybacks
$50.0K repurchased, FY to 2026-06-30
the lowest in Healthcare Services
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch VSEE

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+186.6%12M
-98%+15%+127%+240%2025-102025-122026-022026-042026-062026-082026-10
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns VSEE: institutional holders (13F)

13F holdings, latest reported quarter
ARMISTICE CAPITAL, LLC
4,079,129 sh
$471.5K
JANE STREET GROUP, LLC
785,322 sh
$90.8K
VANGUARD FIDUCIARY TRUST CO
354,298 sh
$41.1K
VANGUARD CAPITAL MANAGEMENT LLC
213,716 sh
$24.8K
GEODE CAPITAL MANAGEMENT, LLC
207,081 sh
$23.9K

Congress trades in VSEE

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

VSEE planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

VSEE mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$69.1K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$24.7K position · as of 2026-06-30
0.0%
Fidelity Nasdaq Composite Index Fund
$2.5K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$1.6K position · as of 2026-05-31
0.0%
Fidelity Total Market Index Fund
$1.9K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 15 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

VSEE financials

Revenue growth
+40.3%
XBRL, annual
Net margin
-100.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$12.6M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-78.3%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$6.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.15x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
-5.65x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
-1,066%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-56.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$109.5M
market value at close 2026-10-27 on 2026-08-12 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
-5.9%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122025-062024-122024-06
Revenue$14.6Mn/a$10.4Mn/a
Gross profit$7.4Mn/a$7.2Mn/a
Operating income-$9.6Mn/a-$62.2Mn/a
Net income-$14.7Mn/a-$57.7Mn/a
EPS (diluted)-58.43n/a-451.99n/a
Operating cash flow-$3.4Mn/a-$5.8Mn/a
Cash$5.1M$291.6K$326.1K$1.1M
Long-term debt$593.9K$593.9K$593.9K$593.9K
Buybacks$44n/a$5.2Kn/a
SEC XBRL, fiscal years, as known on 2026-10-28

VSEE Stock Sonar score 5/7 axes

Find similar shapesCompare

VSEE ranks highest on growth (88th percentile) and risk and compliance (61st), and lowest on profitability (9th), among Healthcare Services peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
9
Inputs
  • Return on equity-1066% · 1 pct, sector of 70
  • Return on assets-56.6% · 16 pct, sector of 88
  • Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
  • Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
37
Inputs
  • Debt to equity0.15x · 65 pct, sector of 61
  • Cash flow to debt-5.65x · 9 pct, sector of 66
Growth
88
Inputs
  • Revenue growth, YoY+40.3% · 88 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
15
Inputs
  • Funds adding, latest quarter15 · 15 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
61
Inputs
  • Short interest, % of floatno short interest or no free float on file
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+8.5% · 61 pct, sector of 72
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies